Details for New Drug Application (NDA): 022067
✉ Email this page to a colleague
NDA 022067 describes FLO-PRED, which is a drug marketed by Sun Pharma Canada and is included in one NDA. There is one patent protecting this drug. Additional details are available on the FLO-PRED profile page.
The generic ingredient in FLO-PRED is prednisolone acetate. There are eighty-eight drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.
The generic ingredient in FLO-PRED is prednisolone acetate. There are eighty-eight drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.
Summary for 022067
| Tradename: | FLO-PRED |
| Applicant: | Sun Pharma Canada |
| Ingredient: | prednisolone acetate |
| Patents: | 1 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | EQ 5MG BASE/5ML | ||||
| Approval Date: | Jan 17, 2008 | TE: | RLD: | No | |||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Oct 11, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patented Use: | TREATMENT OF ALLERGIC REACTIONS | ||||||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Oct 11, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patented Use: | TREATMENT OF ASTHMA | ||||||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | EQ 15MG BASE/5ML | ||||
| Approval Date: | Jan 17, 2008 | TE: | RLD: | No | |||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Oct 11, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patented Use: | TREATMENT OF ALLERGIC REACTIONS | ||||||||
Expired US Patents for NDA 022067
Complete Access Available with Subscription
